Morishita Jintan
Basic Information
- Stock Code
- 4524
- Industry
- Pharmaceuticals
- Category Detail
- Food Manufacturing
- Prefecture
- Osaka Prefecture
- Establishment Year
- November 1936
- Listing Year
- October 1961
- Official Website
- https://www.jintan.co.jp/
- TSE Information
- TSE Information
- Yahoo! Finance
- Yahoo! Finance
- Other Companies
- Sō Iken Holdings, Yomeishu Manufacturing, Ajikan, Senba Tohka, AFC-HD AMS Life Science, Pharmafoods, Euglena, Base Food, Morio Electric
Overview
Morishita Jintan is a long-established company founded in 1936, centered on pharmaceuticals and health foods, with strengths in its proprietary seamless capsule technology and a wide lineup of health-related products.
Current Situation
Morishita Jintan recorded consolidated sales of approximately 9.77 billion yen and operating profit of approximately 450 million yen for the fiscal year ended March 2020, solidifying its position in the pharmaceuticals and health food markets. Its mainstay is contract manufacturing leveraging its representative seamless capsule technology, differentiated by developing health foods using bifidus bacteria and plant extracts. Through business and capital alliances with Rohto Pharmaceutical and expansion of its mail-order business, it has achieved diversification of its customer base and stable revenue generation. Additionally, it focuses on preservation activities for historic town name signs in places like Kyoto and social contributions, maintaining good relations with local communities. Looking ahead, amid rising health consciousness, it will promote the expansion of foods with function claims and actively invest in new product development using seamless capsule technology. While establishing sustainable manufacturing systems and strengthening mail-order channels, it aims to expand performance in the latter half of the 2020s.
Trivia
Interesting Facts
- Unique diplomat mark brand imbued with the founder's sentiments
- Activities to preserve historic enamel town name signs remaining across Japan
- Seamless capsule technology is a pioneer in the food industry
- Jointly participating in numerous product developments with Rohto Pharmaceutical
- Launched Japan's first vitamin D supplement ingestible from 0 years old
- Town name signs preserved as cultural assets in Kyoto
- Mail-order business has a history dating back to the 1990s
- Topic of CM campaigns featuring local voice actors since 2024
- Long-established company with over 130 years since founding
Hidden Connections
- Capital and business alliance with Rohto Pharmaceutical, developing product development and sales collaboration
- Business relationship supplying rose hip extract to Japan Coca-Cola
- Deep ties between Osaka city's historic geography and company identity
- Extensive distribution network through multiple major department stores and drugstores
- Owns specialized subsidiary strong in health food promotions via mail-order
- Crude drug research serves as foundation fusing traditional therapy and modern medical knowledge
- Stable capital with major financial institutions like Mitsubishi UFJ Bank as shareholders
- Unique cultural initiatives to enhance corporate value through regional events and anniversaries
Future Outlook
Growth Drivers
- Market expansion due to increasing health-conscious consumers
- New product development driven by rising demand for foods with function claims
- Strengthening and expansion of mail-order and EC channels
- Expansion of applications for proprietary seamless capsule technology
- Active entry into domestic and international health food markets
Strategic Goals
- Double sales of foods with function claims
- Achieve sustainable raw material procurement rate of over 90%
- Increase mail-order and EC sales ratio to over 50%
- Establish system investing 2 billion yen annually in new product development
- Continuously promote regional cultural preservation activities to enhance brand value
Business Segments
Contract Manufacturing and Technology Provision
- Overview
- Contract manufacturing of foods and health products leveraging proprietary seamless capsule technology.
- Competitiveness
- Differentiation through high-precision capsule technology
- Customers
-
- Major food companies
- Health food manufacturers
- Cosmetics companies
- Research institutions
- Products
-
- Seamless capsule manufacturing
- Material processing
- Raw material supply
- OEM development
Wholesale and Pharmaceutical Sales
- Overview
- Wholesale sales of pharmaceuticals and related products, and supply of medical supplies.
- Competitiveness
- Long-standing trust and diverse product lineup
- Customers
-
- Drugstores
- Pharmacy chains
- Medical institutions
- Home-visit medicine vendors
- Products
-
- Over-the-counter drugs
- Nutritional supplements
- Medical devices
- Thermometers
Mail-order and Marketing Support
- Overview
- Promotion of sales and marketing support for health foods and pharmaceuticals centered on mail-order.
- Competitiveness
- Abundant know-how in mail-order business
- Customers
-
- Individual consumers
- Mail-order businesses
- Health food sales companies
- Products
-
- Foods with function claims
- Beauty and health products
- Online sales platform
Raw Material Supply and Crude Drug Research
- Overview
- Research, development, and supply of crude drug ingredients used in Silver Pellet Jintan.
- Competitiveness
- Fusion of tradition and cutting-edge technology
- Customers
-
- Food manufacturers
- Pharmaceutical manufacturers
- Kampo medicine-related companies
- Products
-
- Crude drug extracts
- Plant-derived ingredients
- Health materials
Competitive Advantage
Strengths
- Uniqueness of seamless capsule manufacturing technology
- Strong brand power in health foods
- Long history and trusted long-established company
- Wide product lineup
- Established mail-order business
- Capital alliance with Rohto Pharmaceutical
- Abundant crude drug raw material research
- Good relationship building with local communities
- Securing diverse sales channels
- Extensive rollout of foods with function claims
Competitive Advantages
- High-quality product manufacturing possible with proprietary seamless capsule technology
- Leader in the health food market differentiated by foods with function claims
- Strength in mail-order, maintaining direct touchpoints with customers
- Brand value from long-term history and trust
- Synergistic effects in technology and sales through capital and business alliance with Rohto Pharmaceutical
- Building entry barriers for competitors through crude drug ingredient R&D
- Stable sales base with multiple sales channels
- Fostering regional brand through town name sign activities as cultural assets
- Diverse product portfolio in pharmaceuticals and health foods
- Stable order acquisition through contract manufacturing for specific customers
Threats
- Intensifying competition in the health food market
- Product labeling and distribution restrictions due to strengthened regulations
- Impact of raw material price fluctuations
- Overheating competition in the mail-order market
- Competitive disadvantage due to delays in technological innovation
- Expansion of new entrants
- Delayed response to diversification of consumer health trends
- Shrinkage of domestic market due to population decline
- Difficulty in stable procurement of raw materials
- Decrease in consumer spending due to changes in economic environment
Innovations
2020: Expansion of 'Health Aid' series of foods with function claims
- Overview
- Refreshed and expanded the lineup of functional foods like Bifina to meet market needs.
- Impact
- Achieved sales growth and improved brand recognition.
2021: Advanced seamless capsule manufacturing equipment
- Overview
- Introduced the latest technology into the production process, significantly improving manufacturing efficiency and quality.
- Impact
- Promoted customer expansion along with improved contract manufacturing capacity.
2022: Acquisition and launch of Cassis-i supplement brand
- Overview
- Acquired blackcurrant product brand from Meiji and rolled out new foods with function claims.
- Impact
- Strengthened competitiveness in the supplement market.
2023: Enhancement of mail-order compatible platform
- Overview
- Revamped EC site and customer management system to expand digital sales ratio.
- Impact
- Stable growth in mail-order sales and improved customer satisfaction.
2024: Initiation of new ingredient development for health foods
- Overview
- Accelerated development of new functional materials based on proprietary crude drug research.
- Impact
- Aims for medium-term product innovation and competitive superiority.
Sustainability
- Reducing factory environmental impact through energy-saving equipment introduction
- Ongoing promotion of regional cultural preservation activities
- Expansion of sustainable raw material procurement
- Efforts to reduce plastic packaging
- Implementation of employee health promotion programs